Market Place
Sourcing Support
LB Pharma Names Heather Turner CEO For Schizophrenia Advances
19 Nov 2024 //
GLOBENEWSWIRE
Roche targets more than $3 billion in annual obesity sales
01 Oct 2024 //
REUTERS
Zealand Pharma Appoints Eric Cox as Chief Commercial Officer
29 Jul 2024 //
GLOBENEWSWIRE
Roche Completes $2.7B Acquisition of Carmot Therapeutics
29 Jul 2024 //
CONTRACT PHARMA
Roche to fast-track weight loss drugs to compete with rivals, FT reports
29 Jul 2024 //
MONEYCONTROL
Roche touts early trial success of second obesity drug candidate
17 Jul 2024 //
PRESS RELEASE
Roche`s $2.7B Carmot bet pays off with ph. 1 weight loss success
16 May 2024 //
FIERCE BIOTECH
Roche trumpets potential ‘best-in-class’ obesity drug
15 May 2024 //
PHARMAPHORUM
Carmot Therapeutics Announces Completion of Acquisition by Roche
29 Jan 2024 //
GLOBENEWSWIRE
Fractyl Health files for IPO to back gene therapy
14 Dec 2023 //
ENDPTS
Roche joins race for obesity drugs with $2.7 billion Carmot deal
05 Dec 2023 //
REUTERS
Carmot Therapeutics Enters into Definitive Merger Agreement with Roche
04 Dec 2023 //
GLOBENEWSWIRE
Obesity and diabetes biotech Carmot Therapeutics files for IPO
17 Nov 2023 //
ENDPTS
Carmot Therapeutics Commenced Phase 2 Clinical Trial of CT-868
15 Nov 2023 //
GLOBENEWSWIRE
Carmot Highlights Clinical Data from its Pipeline of Treatments for Obesity
15 Oct 2023 //
GLOBENEWSWIRE
Carmot Announces that Phase 1 Results Support Oral Dosing for its Obesity
10 Oct 2023 //
GLOBENEWSWIRE
Carmot Announces Presentations Featuring Clinical Data from its Pipeline
26 Sep 2023 //
GLOBENEWSWIRE
Carmot Therapeutics Appoints Charles W. Newton to Board of Directors
19 Jul 2023 //
GLOBENEWSWIRE
Carmot Therapeutics Highlights Clinical Data from its Pipeline of Treatments
23 Jun 2023 //
GLOBENEWSWIRE
Carmot Appoints Michael Gray as CFO and Chief Operating Officer
06 Jun 2023 //
GLOBENEWSWIRE
Carmot raises another $150M for obesity drugs, though race by competitors
26 May 2023 //
ENDPTS
Carmot Therapeutics Raises $150 Million in Series E Equity Financing
25 May 2023 //
GLOBENEWSWIRE
Carmot to Present Data from Pipeline of Treatments for Obesity and Diabetes
23 May 2023 //
GLOBENEWSWIRE
Carmot Therapeutics Launches Spin-Off, Kimia , to Focus on Metabolic Disease
05 Jan 2023 //
GLOBENEWSWIRE
Carmot Announces Significant Leadership Team Expansion with Anne Phillips
21 Sep 2022 //
BUSINESSWIRE
Carmot Therapeutics closes $160M Series D financing
26 Jul 2022 //
BUSINESSWIRE
Carmot to Receive Royalty Payments Upon Sales of Amgen’s FDA Approved LUMAKRAS
29 Jun 2021 //
BUSINESSWIRE
Carmot to Receive Royalty Payments Upon Sales of Amgen’s FDA Approved LUMAKRAS
29 Jun 2021 //
BUSINESSWIRE
Carmot Therapeutics Initiates the Clinical Program for CT-388
26 Jun 2021 //
BUSINESSWIRE
Carmot Announces Investigational New Drug (IND) Clearance for CT-868
04 May 2021 //
BUSINESSWIRE
